Wang D, Grillner S, Wallén P. Endogenous release of 5-HT modulates the plateau phase of NMDA-induced membrane potential oscillations in lamprey spinal neurons. J Neurophysiol 112: 30 -38, 2014. First published April 16, 2014 doi:10.1152/jn.00582.2013The lamprey central nervous system has been used extensively as a model system for investigating the networks underlying vertebrate motor behavior. The locomotor networks can be activated by application of glutamate agonists, such as N-methyl-D-aspartic acid (NMDA), to the isolated spinal cord preparation. Many spinal neurons are capable of generating pacemaker-like membrane potential oscillations upon activation of NMDA receptors. These oscillations rely on the voltage-dependent properties of NMDA receptors in interaction with voltage-dependent potassium and calcium-dependent potassium (K Ca ) channels, as well as low voltage-activated calcium channels. Upon membrane depolarization, influx of calcium will activate K Ca channels, which in turn, will contribute to repolarization and termination of the depolarized phase. The appearance of the NMDAinduced oscillations varies markedly between spinal cord preparations; they may either have a pronounced, depolarized plateau phase or be characterized by a short-lasting depolarization lasting approximately 200 -300 ms without a plateau. Both types of oscillations increase in frequency with increased concentrations of NMDA. Here, we characterize these two types of membrane potential oscillations and show that they depend on the level of endogenous release of 5-HT in the spinal cord preparations. In the lamprey, 5-HT acts to block voltage-dependent calcium channels and will thereby modulate the activity of K Ca channels. When 5-HT antagonists were administered, the plateau-like oscillations were converted to the second type of oscillations lacking a plateau phase. Conversely, plateau-like oscillations can be induced or prolonged by 5-HT agonists. These properties are most likely of significance for the modulatory action of 5-HT on the spinal networks for locomotion. plateau properties; pacemaker-like oscillations; spinal serotonin system; calcium-dependent potassium channels; locomotor network IN ALL VERTEBRATES INVESTIGATED, the networks underlying locomotion are located in the spinal cord, while they are activated by glutamatergic reticulospinal neurons in the brain stem, acting through ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and N-methyl-
IN ALL VERTEBRATES INVESTIGATED, the networks underlying locomotion are located in the spinal cord, while they are activated by glutamatergic reticulospinal neurons in the brain stem, acting through ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and N-methyl-D-aspartic acid (NMDA) receptors (Grillner 2006; Ohta and Grillner 1989) . Descending pathways and intraspinal neurons using 5-HT as a transmitter also play an important role in many vertebrates (Jordan et al. 2008; Schotland et al. 1995) . 5-HT acts through voltagedependent calcium channels, which in turn, control the postspike afterhyperpolarization via calcium-dependent potassium (K Ca ) channels [lamprey: Hill et al. (2003) and Wallén et al. (1989) ; rat: Bayliss et al. (1995) and Blomeley and Bracci (2005) ; turtle: Hounsgaard and Kiehn (1989) ; frog: Scroggs and Anderson (1989) and Sun and Dale (1998) ] and also acts through presynaptic inhibition [lamprey: Buchanan and Grillner (1991) and Schwartz et al. (2005) ; mouse: Garcia-Ramirez et al. (2014) ; frog: Sillar and Simmers (1994b) ]. In the lamprey, administration of 5-HT agonists slows down the locomotor activity and makes the bursts more intense (Harris-Warrick and Cohen 1985) . Conversely, administration of 5-HT antagonists during locomotor activity leads to a pronounced increase of the locomotor frequency (Zhang and Grillner 2000) .
In the lamprey, the locomotor networks can be activated by superfusion of NMDA to the isolated spinal cord preparation (Grillner et al. 1981) . The motor activity can be recorded from the ventral roots or from motoneurons and interneurons intracellularly. The key elements of the segmental and intersegmental networks responsible for generating the locomotor activity have been identified, and they consist of ipsilateral excitatory interneurons and commissural inhibitory interneurons (Buchanan and Grillner 1987; Grillner 2003; Kozlov et al. 2009 ).
In the isolated spinal cord, after cellular interactions have been blocked through administration of TTX, the activation of NMDA receptors generates pacemaker-like oscillations in many neurons, which rely on the voltage-dependent properties of NMDA receptors in interaction with voltage-dependent potassium and K Ca channels (Wallén and Grillner 1987) . NMDA receptor-mediated, TTX-resistant membrane potential oscillations can contribute to the generation of locomotor activity and have also been demonstrated in other species, including rodents (Hochman et al. 1994; MacLean et al. 1997; Masino et al. 2012; Schmidt et al. 1998 ) and amphibians (Li et al. 2010; Reith and Sillar 1998; Scrymgeour-Wedderburn et al. 1997 ). In the lamprey, these oscillations vary in a characteristic way between different spinal cord preparations. In some preparations, there is a pronounced, depolarized plateau phase, which can be prolonged further by a blockade of K Ca channels via administration of 5-HT or specific antagonists, such as apamin (El Manira et al. 1994) . In other preparations, there are instead more short-lasting depolarizations without any plateau phase [cf. Wang et al. (2013) ], lasting approximately 200 -300 ms. In the present study, we characterize these two types of oscillations and show that they depend on the level of endogenous release of 5-HT in the spinal cord preparations. The plateaulike oscillations are converted to the second type of oscillations lacking a plateau phase when 5-HT antagonists are administered, and conversely, plateau-like oscillations can be induced or prolonged by 5-HT agonists. These properties most likely play a role in the generation of locomotor activity by the spinal networks.
MATERIALS AND METHODS
Ethical approval. All experimental procedures were approved by Stockholm Norra Försöksdjursetiska Nämnd, according to the Swedish regulations for the care and use of laboratory animals. Before removal of the tissue, the animals were deeply anesthetized (MS-222, tricaine methanesulfonate, 100 mg/l, dissolved in water; Sigma, St. Louis, MO) and killed by decapitation.
In vitro lamprey spinal cord preparation. Experiments were performed using isolated spinal cord preparations of adult river lampreys (Lampetra fluviatilis; n ϭ 31) or in a few cases, American silver lampreys (Ichthyomyzon unicuspis; n ϭ 2). Results obtained from the two species were indistinguishable. In previous studies, no differences in cellular properties of spinal neurons in the two species have been observed. A spinal cord piece comprising 10 -15 segments was dissected from a region caudal to the gills. The spinal cord was isolated from the notochord and placed with the ventral side up into a Sylgard-lined (Dow Corning, Midland, MI) recording chamber. The meninges were stripped from the ventral surface, and in most cases, ventral roots were drawn into the tips of glass suction electrodes for motoneuron identification. The chamber was perfused continuously with oxygenated lamprey physiological solution containing (in mM): 138 NaCl, 2.1 KCl, 1.8 CaCl 2 , 1.2 MgCl 2 , 4 glucose, 2 HEPES, and 0.5 L-glutamine, bubbled with O 2 and adjusted to pH 7.4 with NaOH. The experimental chamber was cooled to maintain the preparation at 6 -10°C.
Drugs used were NMDA (Tocris, Bristol, UK); TTX (final concentration 1.5 M; Sigma); 5-HT (1 M; Tocris), spiperone hydrochloride, a 5-HT antagonist (10 M; Tocris); NAD 299 hydrochloride, a specific 5-HT 1A antagonist [(3R)-3-(dicyclobutylamino)-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide hydrochloride, 10 -20 M; Tocris]; and nimodipine, an L-type calcium channel antagonist [1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methyloxyethyl 1-methylethyl ester, 10 M; Tocris]. All drugs were applied to the perfusion solution. NMDA was applied in incremental concentration steps of 50 M, from 50 to 200 M or in one case, to 250 M.
Electrophysiology. To induce NMDA receptor-dependent, TTXresistant oscillations, NMDA and TTX were added in the physiological solution (Wallén and Grillner 1987) . Combined results from 9 neurons tested. The overall frequency range was 0.08 -0.54 Hz. The higher doses resulted in higher frequency, with the more marked increase commonly occurring from 100 to 150 M. In several cells, the dose-frequency relation tended to saturate at the highest dose (200 M). Each point represents the average frequency from 10 cycles at each concentration in an individual neuron. C: the influence of changing the NMDA concentration on the structure of the oscillatory cycle. Inset: the different parameters measured: cycle duration, time from 1 depolarization peak to the next; amplitude, voltage deflection from trough to peak; half-width, duration of depolarized plateau at half-maximal amplitude (½). These parameters were analyzed in 5 cells with plateau-like oscillations: cycle duration (C1), amplitude (C2), half-width (C3), and half-width normalized to cycle duration (C4 Fig. 1C1, inset) . Parameter values are given as means Ϯ SD, with levels of significance: *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001.
RESULTS
Upon application of NMDA and in the presence of TTX, many neurons in the lamprey spinal cord will generate endogenous, pacemaker-like membrane potential oscillations Grillner 1985, 1987) . These oscillations are strongly voltage dependent, and previous reports have also suggested a positive correlation between the frequency of the oscillations and the NMDA concentration (Huss et al. 2008; Sigvardt et al. 1985; Wallén and Grillner 1987) .
The NMDA-induced, TTX-resistant membrane potential oscillations vary in shape between different spinal cord preparations; the oscillations may be "plateau like" with a pronounced, depolarized plateau phase (cf. Fig. 1A ) but may in other preparations appear "spike like" with a short-lasting depolarization and no evident plateau phase (cf. Fig. 2A ). Below, we will characterize these two forms of oscillation by a quantitative analysis of the effects of varying the NMDA concentration. In addition, we describe the modulatory influence of endogenous 5-HT release on the oscillations.
Dependence of the membrane potential oscillations on NMDA concentration. In most cells of the lamprey spinal cord, the threshold concentration of NMDA to induce membrane potential oscillations is approximately 50 -100 M (Wallén and Grillner 1987) . Figure 1A illustrates one neuron where 100 M NMDA induced rhythmic plateau oscillations at a rate of ϳ0.2 Hz (Fig. 1A1) . Increasing the NMDA concentration to 150 M (Fig. 1A2 ) caused an increase in frequency to ϳ0.25 Hz, whereas a higher concentration did not result in any obvious, further increase in the rate of oscillations (Fig. 1, A3 and A4). In general, there was a tendency to reach "saturation" ϳ150 M, with no further increase in the rate of oscillations with higher levels of NMDA (Fig. 1B) . During NMDA-induced fictive locomotor activity in the spinal network, a corresponding relation is seen (Brodin et al. 1985) .
The influence of varying the NMDA concentration on different parameters characterizing the oscillatory behavior was analyzed further in 10 spinal cord neurons (of which three were identified as motoneurons), with five cells showing plateau-like oscillations ( trough-to-peak amplitude, ranging between 13 and 28 mV, showed a variable dependence on NMDA concentration among the cells (Fig. 1C2 ). The width of the depolarized plateau at half-maximal amplitude (half-width; see inset in Fig. 1C1 ) was typically ϳ1 s or longer and showed an increase with higher NMDA levels in four cells and a decrease in one neuron (Fig.  1C3 ). Normalized to the cycle duration, the half-width ranged between ϳ13% and 57% of the cycle duration (Fig. 1C4) . NMDA-induced oscillations characterized by shorter depolarization peaks, without a prolonged plateau, are illustrated in Fig. 2 . The spike-like oscillations also increased in frequency, with higher concentrations of NMDA ( Fig. 2A) . As with plateau-like oscillations, a saturation level was generally seen for spike-like oscillations in the relationship between NMDA concentration and rhythm frequency. In general, the cycle durations as well as the amplitudes were within the same range for cells with plateau-and spike-like oscillations. The effects of varying the NMDA concentration on different oscillatory parameters were also similar in cells displaying spike-like oscillations (Fig. 2B ) compared with those described above for plateau-like oscillations. In all of the five cells analyzed, cycle duration became significantly shorter with higher concentrations of NMDA (Fig. 2B1) . Four of the five cells showed a significant increase in oscillation amplitude with higher NMDA levels (Fig. 2B2) . The brief depolarization peaks of spike-like oscillations consequently occupied a small proportion of the cycle, with the half-width varying between 0.2 and 0.4 s at the lowest NMDA concentration (Fig. 2B3) , corresponding to a range between 2% and 10% of the cycle (Fig.  2B4 ). Higher NMDA concentrations caused a significant increase of the normalized half-width in all five tested cells with spike-like oscillations (Fig. 2B4) . Even so, the half-width values were typically Ͻ10% of the cycle even with higher levels of NMDA.
The NMDA-induced oscillations are strongly dependent on the membrane potential level Grillner 1985, 1987) . We therefore also analyzed the effects of varying the NMDA concentration at two different holding potential levels (n ϭ 5; Fig. 3) . Figure 3A illustrates spike-like oscillations recorded at a holding potential of Ϫ70 mV (Fig. 3, A1 and A2 ) and at Ϫ75 mV (Fig. 3, A3 and A4) and with two different levels of NMDA. Increasing the concentration of NMDA increased the oscillation frequency at both holding potential levels, but the effect was more prominent at the Ϫ70-mV level, thus giving a steeper relation between NMDA concentration and oscillation frequency (Fig. 3B) . Corresponding results were also found in four neurons displaying plateau-like oscillations (not illustrated).
The effects on the structure of the oscillation cycle of the cell in Fig. 3, A and B, are illustrated in Fig. 3C . Corresponding to the graph in Fig. 3B , the cycle duration (Fig. 3C1) was significantly longer at the more hyperpolarized level with the higher NMDA concentration (150 M), whereas with 100 M NMDA, there was no difference. The oscillation amplitude (Fig. 3C2) was significantly larger at Ϫ75 mV and with both NMDA concentrations. The half-width (Fig. 3C3) did not Each point represents the frequency from 10 cycles. At the more depolarized holding potential level, the relation is steeper. C: cycle structure analysis of oscillations in the same neuron as in A (cf. Fig. 1C1, inset) . Average values from 20 cycles of oscillation. Cycle duration (C1) was increased significantly at the more hyperpolarized level and with the higher NMDA concentration, whereas the amplitude (C2) increased significantly upon hyperpolarization with both high and low NMDA concentration. Half-width (C3 and C4) was decreased significantly at the more hyperpolarized level with 150 M NMDA but only when expressed as normalized values (C4). Student's t-test, means Ϯ SD; comparison of 100 M group vs. 150 M group: *P Ͻ 0.05, ***P Ͻ 0.001; comparison of Ϫ70 mV vs. Ϫ75 mV group: ϩϩP Ͻ 0.01, ϩϩϩP Ͻ 0.001. change with the holding potential, except when expressed as normalized half-width and with the higher NMDA concentration (Fig. 3C4) . A general conclusion from these findings is thus that for both types of membrane potential oscillations, higher levels of NMDA receptor activation will result in an increased oscillation frequency until a saturation level is reached. Also, in most cases, there is an increase in oscillation amplitude and in half-width duration with higher NMDA concentrations.
Serotonergic modulation of membrane potential oscillations. It is thus clear that the NMDA-induced membrane potential oscillations may vary between different spinal cord preparations. In some, the oscillations are plateau like, whereas in other preparations, there are instead spike-like oscillations, lasting approximately 200 -300 ms without any plateau phase. One may then ask whether this difference reflects different states of the preparations and if the two forms of oscillations may occur in the same cell.
Differences in the functional state may be caused by influence from various modulatory systems. The duration of the depolarized plateau is prolonged by a partial blockage of K Ca channels by apamin, and these channels are also depressed by 5-HT (El Manira et al. 1994; Wallén et al. 1989; Wallén and Grillner 1987) . The possibility that the oscillations may be subject to an endogenous modulation by the spinal 5-HT system was first investigated by bath application of spiperone, a 5-HT antagonist (Hoyer et al. 1994; Metwally et al. 1998; Zhang and Grillner 2000) . Spiperone was previously shown to increase the frequency of fictive locomotion induced by NMDA, as well as the variability of the rhythmic activity (Zhang and Grillner 2000) , indicating an endogenous release of 5-HT during fictive locomotion.
When spiperone was applied during plateau-like oscillations (Fig. 4, A and B) , the plateau phase became progressively shorter (Fig. 4A2) , and eventually, the oscillations were converted to the spike-like form, with no plateau phase ( Fig. 4A3 ; n ϭ 6). When 5-HT was then applied, the oscillations partly reverted back to the plateau-like form (Fig. 4A4) . Spiperone thus caused a marked and significant reduction in the halfwidth of the depolarized phase (Fig. 4B) , seen in all six cells tested. Due to the possibility that spiperone may, in addition, act as a dopamine receptor antagonist (Metwally et al. 1998; Seeman and Van Tol 1994) , we also tested the effect of the specific 5-HT 1A antagonist NAD 299 (Johansson et al. 1997) (Fig. 4, C and D; n ϭ 6) , which like spiperone, altered the plateau-like oscillations to become more spike like (Fig. 4C2) , and after subsequent application of 5-HT, the plateau phase was re-established (Fig. 4, C3 and C4 ). Like spiperone, NAD 299 caused a significant reduction in the half-width (Fig. 4D) . Thus by blocking 5-HT receptors, the plateau-like oscillations are converted to the spike-like form, suggesting that 5-HT is endogenously released and causes a prolongation of the plateau phase. This modulatory action of 5-HT may primarily be mediated via 5-HT 1A receptors. The converse experiment is illustrated in Fig. 5 , where the control oscillations are of the spike-like form (Fig. 5, A1 and  C1) . After application of 5-HT, the oscillations were converted to the plateau-like form (Fig. 5, A2 and C2 ; n ϭ 6). When spiperone was also applied, the oscillations again became spike like (Fig. 5A3) , as was the case upon application of NAD 299 (Fig. 5C3) . Application of 5-HT thus caused a significant prolongation of the half-width of the depolarized phase during plateau-like oscillations, an effect that was markedly counteracted by subsequent application of either of the two antagonists (Fig. 5, B and D) . Thus 5-HT will act to promote a transition from spike-like to plateau-like oscillations, whereas blocking the influence of 5-HT will convert the oscillations back to the spike-like form. An altered level of 5-HT tone in the spinal cord may thus modulate the oscillatory activity and cause a switch from one form of oscillation to the other.
5-HT indirectly blocks K Ca channels through an action on voltage-dependent calcium channels (Hill et al. 2003) . Moreover, 5-HT acts on low-threshold L-type calcium channels (Ca V 1.3) to modulate the postinhibitory rebound (PIR) response in lamprey spinal neurons (Wang et al. 2011) . We have reported recently that during NMDA-induced membrane potential oscillations, low voltage-activated (LVA) calcium channels of the Ca V 1.3 subtype will contribute (Wang et al. 2013 ). We therefore tested whether the modulatory influence of 5-HT on the oscillations is exerted solely via an action on L-type calcium channels or if other routes of action may also contribute. Application of the L-type calcium channel antagonist nimodipine prolongs the plateau phase of the oscillations, as does 5-HT (Fig. 6 , A and B) (Wang et al. 2013 ). In the presence of nimodipine, 5-HT was, however, still able to prolong the plateaus further ( Fig. 6C; n ϭ 3) , suggesting that the action of 5-HT on NMDA-induced membrane potential oscillations is not only exerted via a blockade of L-type calcium channels (Ca V 1.3).
DISCUSSION
NMDA can induce pacemaker-like oscillations in different neurons in the lamprey spinal cord and in other species (Hochman et al. 1994; Li et al. 2010; Masino et al. 2012; Sigvardt et al. 1985; Wallén and Grillner 1987) after a blockade of interaction between the cells with tetrodotoxin. The generation of these plateaus depends on an interaction between a number of ion channels. The voltage dependence of the NMDA receptors is central to the oscillations, but the depolarization is counteracted by voltage-dependent potassium channels, and LVA calcium channels also contribute to the depolarization Wang et al. 2013) . The termination of the plateau phase is due to activation of K Ca channels and a closure of the voltage-dependent NMDA receptors (El Manira et al. 1994; Wallén and Grillner 1987) .
It has long been noted that these oscillations in the lamprey can either have a pronounced, depolarized plateau phase or show a continuous decrease of the amplitude after the peak without a significant plateau. Different spinal cord preparations have been found predominantly to express either of these two types of pacemaker-like oscillations. We have here first characterized the properties of these two versions. Both types of oscillations show a similar dependence on the level of NMDA receptor activation, indicating that the same ion channel mechanisms underlie both types [cf. Wallén and Grillner (1987) ; Wang et al. (2013) ]. On the basis of these findings, we then set out to investigate whether differences in modulatory, serotonergic influence may explain the presence of the two types of oscillations in different preparations. We now show that this appears to be the case and that the spinal 5-HT system indeed may contribute to the shape of the oscillations. A related finding is that Zhang and Grillner (2000) have shown that during fictive locomotion, a blockade of 5-HT receptors led to marked acceleration of the frequency of locomotor activity, suggesting that there was a tonic release of 5-HT affecting the locomotor frequency. This is most likely caused by the intraspinal 5-HT neurons located below the central canal (Schotland et al. 1995; Zhang et al. 1996) .
The plateau-like oscillations induced by NMDA in the spinal cord preparation were transferred to the spike-like form of oscillations after a blockade of 5-HT receptors with spiperone [cf. Zhang and Grillner (2000) ] and also with NAD 299, a specific 5-HT 1A antagonist. This suggests that there is an endogenous release of 5-HT also during the oscillations. Furthermore, since this release is maintained in the presence of TTX, it may occur spontaneously in the absence of spikes. The release of 5-HT causes a depression of K Ca channel activation (El Manira et al. 1994; Wallén et al. 1989 ) and thereby a prolongation of the plateau, and consequently, a blockade of 5-HT receptors will enhance the level of K Ca channel activity, which will terminate the plateau-like oscillations earlier and make them spike like. Conversely, an enhanced level of 5-HT, as during external application in the present experiments, will depress K Ca channel activation and thereby transform the spike-like oscillations to the more plateau-like version. Application of 5-HT is also known to slow down the locomotor frequency (Harris-Warrick and Cohen 1985) . A modulation of TTX-resistant NMDA oscillations by 5-HT occurs in several species, including rodents (Hsiao et al. 2002; MacLean et al. 1998; MacLean and Schmidt 2001; Masino et al. 2012; Schmidt et al. 1998) , amphibians (Reith and Sillar 1998; Scrymgeour-Wedderburn et al. 1997; Sillar and Simmers 1994a; Sillar et al. 1992) , and lamprey [present study and El Manira et al. (1994) ; Wallén et al. (1989) ].
5-HT will reduce K Ca channel activation through an action on voltage-dependent calcium channels (Hill et al. 2003) . During NMDA-induced membrane potential oscillations, which range between approximately Ϫ70 and Ϫ40 mV, LVA calcium channels of the Ca V 1.3 subtype contribute to K Ca channel activation, in addition to calcium entry via other routes, notably NMDA receptor channels Nanou et al. 2013; Wang et al. 2013) . We have furthermore shown that this subtype of LVA calcium channel also contributes to the PIR response in lamprey spinal neurons and that 5-HT acts on the Ca V 1.3 subtype to modulate the PIR (Wang et al. 2011 ). In the case of the 5-HT modulation of the NMDA-induced membrane potential oscillations studied here, the action appears not to be mediated only via Ca V 1.3 subtype calcium channels, since in the presence of nimodipine, 5-HT application still resulted in a prolongation of the plateau phase (Fig. 6) . Instead, 5-HT may here exert its action by also blocking other routes of calcium entry, thereby reducing K Ca channel activation.
The explanation for the difference between preparations with more spike-like oscillations and those with plateaus thus appears to be the degree of activity in the spinal 5-HT system [cf. Zhang et al. (1996) ]. Preparations with a high level of 5-HT activity will show plateau-like oscillations, whereas those with a lower level of 5-HT activity will show spike-like oscillations. We thus have demonstrated a mechanism that can account for the difference between the two conditions. The endogenous level of 5-HT in the spinal cord may thus regulate the motor output, at least partly, by influencing the oscillatory properties of neurons in the locomotor network. An increased level of 5-HT would then be expected to cause longer oscillation plateaus and thereby, longer bursts, resulting in slower and possibly more forceful locomotor movements. A lower level of 5-HT release would instead result in shortening of oscillation plateaus and shorter locomotor bursts of higher rate. It is conceivable that slower and more forceful undulatory movements would be required, for example, during swimming against increased water current or during burrowing behavior.
